About 8 Invent

8Invent represents a groundbreaking advancement in the field of intellectual property (IP) generation, leveraging a proprietary universal inversion system to transform existing concepts into novel, patentable inventions. This innovation addresses critical challenges in the innovation ecosystem, offering a scalable solution for businesses, patent attorneys, and investors alike. Drawing inspiration from successful models in sustainable energy and biotechnology, 8Invent positions itself at the intersection of technology, creativity, and commercial viability, with a clear path to market leadership.

The Opportunity in Converging Markets

The global landscape for IP and innovation is expansive and rapidly evolving. The patent services market alone is valued at approximately $150 billion, characterized by inefficiencies in generation and protection. Biotechnology, a $500 billion sector, is shifting toward rapid IP development to secure competitive advantages. Additionally, the IP licensing market, estimated at $100 billion, is constrained by slow creation processes that hinder timely commercialization. 8Invent capitalizes on these opportunities by providing a system that accelerates IP generation by up to tenfold, enabling stakeholders to meet the demands of high-growth industries.

1
Traditional Innovation
Traditional innovation processes are plagued by systemic issues. Businesses face economic losses from overlooked IP opportunities in existing technologies, resulting in missed revenue streams and weakened market positions. Environmental costs arise from inefficient R&D practices that consume excessive resources and time. Security risks, including IP theft and supply chain vulnerabilities, further exacerbate these challenges, leaving companies exposed to global fluctuations.
Learn More
1
Patent Offices
For patent attorneys, the burdens include time-intensive prior art searches, ambiguous client briefs, and elevated rejection risks due to insufficient novelty assessments. These factors reduce efficiency and increase operational costs.
Learn More
Investors
Investors encounter even greater hurdles, often committing capital to "one pony" companies with limited recourse. A notable example is Opthea Limited, where a single clinical failure led to substantial shareholder losses exceeding $100 million. Such scenarios highlight the need for diversified, resilient investment vehicles that mitigate risks through robust IP portfolios.
Learn More

A Comprehensive 'Idea to Patent' Ecosystem.

8Invent’s core technology is the universal inversion system, a provisionally patented methodology that reimagines existing ideas to produce novel inventions. This goes beyond basic ideation, incorporating AI-driven controls for reliable, low-cost patent generation. Validated through collaborations with leading Australian universities, the system has demonstrated efficiency in simulations, including over 2 million Monte Carlo iterations to optimize inversion kinetics.

The ecosystem includes modular products tailored for various sectors: small-scale inversion systems for instant novelty assessment in biotech firms, large-scale AI platforms for continuous patent creation in industrial R&D, and the universal inversion engine, which achieves 97% efficiency in generating non-obvious IP. This circular approach ensures scalable, on-demand innovation, aligning with sustainable practices.

Traction and Validation

8 Invent envisions a future where inventors and professionals can focus on business, while our system seamlessly manages invention discovery, finding new and defensible patent art, with new patent claims—increasing your IP and company valuation – faster than anyone else can

Our Vision

We envision a healthcare landscape where technology enhances human connection rather than hindering it. Where compliance happens naturally. Where healthcare workers can be fully present with their participants because the system handles the rest. Every voice recording becomes structured documentation. Every device reading becomes valuable health data. Every interaction becomes part of a comprehensive care story—all without lifting a finger to type.

Email Us

Reach out to GreyCorp AI via email at [email protected] for inquiries, support, or to request a demo. Our team is ready to assist you with tailored solutions for your industry.

Call Us

Speak directly with our AI Agent at +61 488 860 780 . We are available Monday to Friday, 9am to 5pm

Visit Us

Our headquarters are located at 14/117 Old Pittwater Road, Brookvale, NSW 2100 Australia